Biomedical Bonding AB is happy to announce that it has secured the trademark BONEVOLENT® for the European market.
BONEVOLENT™ covers:
1. Bone fixation implants; Osseous implants; Artificial bone materials; Bone void fillers consisting of artificial materials; Bone substitutes for surgical use; Apparatus for use in the repair of bones; Surgical instruments.
2. Synthetic material for use in setting bones; Surgical glues; Adhesive compositions for medical use; Dental restoration compounds; Dental materials for stopping the teeth; Dental bonding material; Teeth filling material.
For more information contact Michael Malkoch, CEO of Biomedical Bonding AB, at michael.malkoch@biomedicalbonding.com
Kommentare